Assess, identify, treat and repeat
Encouraging clinical efficacy with no rise in adverse events
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Initiative improves access to specialists, advanced treatments
Surprising outcome differs from previous results
Study finds good hematologic response and rapid action
May extend disease-free and overall survival with good quality of life
Luspatercept shows promise for patients with few options
Searching for new insights into drug resistance, collateral sensitivity
Advertisement
Advertisement